SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : North American Vaccine
NVX 1.410-6.6%Nov 3 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Stone who wrote (33)10/29/1996 7:53:00 PM
From: Rick Strange   of 82
 
Tom, I'm confussed. At 17:53 NVX filed a story on Business Wire that announced that "the FDA Vaccine and Related Biological Advisory Committee concluded that CERTIVA(TM), North American Vaccine's combined diphtheria, tetnus and accellular pertussis (whooping cough) vaccine, is safe and effective for administration in infants at 2,4,6 and 15-18 months of age."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News